Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report aliu Thu, 11/19/2020 – 09:22

Cognitive decline in widowsOlder men and women whose husbands or wives have died are particularly susceptible to the […]

New findings from phase 2 study published in The Lancet

CGRP antagonist approved to prevent migraine in adults with episodic and chronic migraine

Trial will evaluate whether Mavenclad can slow the rate of upper limb disability progression

Combination treatment scored EU approval earlier this year

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST

Updated Date: Thu, 12 Nov 2020 00:00:00 EST